Maridea Wealth Management LLC raised its holdings in shares of Omega Healthcare Investors, Inc. (NYSE:OHI – Free Report) by 1.7% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,146 shares of the real estate investment trust’s stock after acquiring an additional 329 shares during the period. Maridea Wealth Management LLC’s holdings in Omega Healthcare Investors were worth $702,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently modified their holdings of the company. NBC Securities Inc. acquired a new position in shares of Omega Healthcare Investors in the 1st quarter worth $29,000. Park Square Financial Group LLC acquired a new position in shares of Omega Healthcare Investors in the 4th quarter worth $61,000. MassMutual Private Wealth & Trust FSB grew its holdings in shares of Omega Healthcare Investors by 562.3% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 1,828 shares of the real estate investment trust’s stock worth $67,000 after acquiring an additional 1,552 shares during the last quarter. UMB Bank n.a. grew its holdings in shares of Omega Healthcare Investors by 94.9% in the 1st quarter. UMB Bank n.a. now owns 2,175 shares of the real estate investment trust’s stock worth $83,000 after acquiring an additional 1,059 shares during the last quarter. Finally, Meeder Asset Management Inc. grew its holdings in shares of Omega Healthcare Investors by 1,581.3% in the 1st quarter. Meeder Asset Management Inc. now owns 2,522 shares of the real estate investment trust’s stock worth $96,000 after acquiring an additional 2,372 shares during the last quarter. Institutional investors own 65.25% of the company’s stock.
Insider Buying and Selling
In related news, Director Lisa Egbuonu-Davis sold 2,500 shares of the stock in a transaction that occurred on Friday, August 8th. The stock was sold at an average price of $40.16, for a total transaction of $100,400.00. Following the sale, the director directly owned 18,654 shares in the company, valued at $749,144.64. This represents a 11.82% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.50% of the stock is currently owned by company insiders.
Omega Healthcare Investors Price Performance
Omega Healthcare Investors (NYSE:OHI – Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share for the quarter, topping the consensus estimate of $0.45 by $0.32. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The business had revenue of $235.60 million during the quarter, compared to analysts’ expectations of $248.49 million. During the same quarter in the previous year, the firm earned $0.71 EPS. The firm’s revenue was up 11.8% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. Research analysts anticipate that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current year.
Omega Healthcare Investors Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Monday, August 4th were given a dividend of $0.67 per share. The ex-dividend date was Monday, August 4th. This represents a $2.68 dividend on an annualized basis and a yield of 6.5%. Omega Healthcare Investors’s dividend payout ratio is 165.43%.
Analysts Set New Price Targets
A number of research analysts have recently weighed in on the company. Royal Bank Of Canada lifted their price target on Omega Healthcare Investors from $39.00 to $41.00 and gave the company a “sector perform” rating in a report on Thursday, August 7th. Raymond James Financial reiterated an “outperform” rating on shares of Omega Healthcare Investors in a report on Tuesday, September 2nd. Wells Fargo & Company lifted their price target on Omega Healthcare Investors from $41.00 to $44.00 and gave the company an “overweight” rating in a report on Wednesday, August 27th. Scotiabank lifted their price target on Omega Healthcare Investors from $39.00 to $42.00 and gave the company a “sector perform” rating in a report on Thursday, August 28th. Finally, Mizuho lifted their price target on Omega Healthcare Investors from $37.00 to $40.00 and gave the company a “neutral” rating in a report on Thursday, September 11th. Five analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $43.75.
Check Out Our Latest Analysis on OHI
Omega Healthcare Investors Company Profile
Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.
Recommended Stories
- Five stocks we like better than Omega Healthcare Investors
- Options Trading – Understanding Strike Price
- Cybersecurity Market Set to Double: This ETF Offers Exposure
- What is diluted earnings per share (Diluted EPS)?
- Downgraded But Not Done: 3 Stocks Ready for a Market Comeback
- What Are Dividends? Buy the Best Dividend Stocks
- Solana Beat BTC and ETH in Q3: These 3 Stocks Saw It Coming
Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHI – Free Report).
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.